Bile Duct Cancer

Showing 1 - 25 of 69

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional

Enrolling by invitation
  • Ampullary Cancer
  • +3 more
  • Modified Blumgart Anastomosis in LPD
  • conventional Blumgart anastomosis in LPD
  • Zhanjiang, Guangdong, China
    The Affiliated Hospital of Guangdong Medical University
Oct 7, 2023

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

ful Mutations in Solid Tumor Characterized by Next Generation

Recruiting
  • Solid Tumor
  • +13 more
    • Aviano, Pordonone, Italy
      IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
    Sep 8, 2023

    Bile Duct Cancer Trial (envolizumab , sovalteinib)

    Not yet recruiting
    • Bile Duct Cancer
    • envolizumab , sovalteinib
    • (no location specified)
    Jun 20, 2023

    Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

    Not yet recruiting
    • Biliary Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

    Not yet recruiting
    • Melanoma
    • +16 more
    • Darlinghurst, New South Wales, Australia
    • +3 more
    May 12, 2023

    Looking At Bile Duct Cancer Patient Experience Patterns in

    Not yet recruiting
    • Bile Duct Cancer
      • (no location specified)
      Jan 20, 2023

      Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

      Not yet recruiting
      • Bile Duct Cancer
      • +4 more
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jan 23, 2023

      Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

      Recruiting
      • Metastatic Colorectal Cancer (Mcrc)
      • +7 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

      Recruiting
      • Advanced Cancer
      • +24 more
      • pembrolizumab
      • Los Angeles, California
      • +21 more
      Jan 18, 2023

      Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

      Recruiting
      • Minimal Residual Disease
      • +11 more
      • ELI-002 2P
      • Duarte, California
      • +10 more
      Jan 18, 2023

      Recurrence After Whipple's (RAW) Study

      Active, not recruiting
      • Pancreatic Cancer
      • +13 more
      • Pancreaticoduodenectomy
      • Clayton, Victoria, Australia
      • +28 more
      Jan 13, 2023

      Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

      Recruiting
      • Peritoneal Carcinomatosis
      • +7 more
      • PIPAC with Nal-IRI
      • Ghent, East-Flanders, Belgium
        UZ Ghent
      Dec 28, 2022

      Liver and Biliary Cancer Patients Treated With PD-1 Combination

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Bile Duct Cancer
      • [68Ga]FAPI PET/CT and [18F]FDG PET/CT
      • Beijing, China
        Department of Nuclear Medicine, Peking Union Medical College Hop
      Dec 14, 2022

      Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)

      Terminated
      • Cholangiocarcinoma
      • Bile Duct Cancer
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Nov 28, 2022

      Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

      Recruiting
      • Adenocarcinoma
      • +75 more
      • Biomarker Testing (L)
      • +2 more
      • Idaho Falls, Idaho
      • +1 more
      Oct 18, 2022

      Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +8 more
      Aug 18, 2022

      Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

      Active, not recruiting
      • Breast Cancer
      • +10 more
      • Los Angeles, California
      • +7 more
      Jun 21, 2022

      Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)

      Recruiting
      • Inoperable Disease
      • Bile Duct Cancer
      • Endoscopic ultrasound with fine needle biopsy
      • Cluj-Napoca, Cluj, Romania
        IRGH "O. Fodor"
      Jun 14, 2022

      Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

      Active, not recruiting
      • Biliary Tract Neoplasms
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Mar 1, 2022

      Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)

      Active, not recruiting
      • Bile Duct Cancer
      • Intrahepatic Cholangiocarcinoma
      • Melphalan/HDS
      • Cisplatin and Gemcitabine
      • Durham, North Carolina
      • +2 more
      Mar 23, 2022

      Adverse Drug Event, Colon Cancer, Breast Cancer Trial in Odense (DPYD genotype)

      Recruiting
      • Adverse Drug Event
      • +7 more
      • DPYD genotype
      • Odense, Syddanmark, Denmark
        The Department of Oncology at University of southern denmark
      Mar 3, 2022

      Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

      Recruiting
      • Pancreatic Cancer
      • +49 more
        • Colorado Springs, Colorado
        • +80 more
        Feb 22, 2022

        Bile Duct Cancer Trial in France (GEMCIS, mFolfirinox)

        Completed
        • Bile Duct Cancer
        • Amiens, France
        • +41 more
        Feb 23, 2022